ALX Oncology
ALXO
$14.21
Share price
-3.07%
Change (1 day)
125.20%
Change (1 year)
Categories
Earnings for ALX Oncology (ALXO)
Earnings in 2023 (TTM): -$0.16 B
According to ALX Oncology's latest financial reports the company's current earnings (TTM) are -$0.16 B. In 2022 the company made an earning of -$0.13 B a decrease over its 2021 earnings that were of -$83.54 M.The earnings displayed on this page is the company's Pretax Income.
Earnings history for ALX Oncology from 2019 to 2023
Annual earnings
| Year | Earnings | Change |
|---|---|---|
2023 (TTM)  | -$0.16 B | 27.41% |
| 2022 | -$0.13 B | 49.61% |
| 2021 | -$83.54 M | 86.94% |
| 2020 | -$44.69 M | 132.9% |
| 2019 | -$19.19 M |
Earnings for similar companies or competitors
| Company | Earnings | Earnings differencediff. | Country |
|---|---|---|---|
 ORIC Pharmaceuticals
ORIC | -$0.12 B | -30.43% | 🇺🇸 USA |